CHAPEL HILL, N.C.--(BUSINESS WIRE)--POZEN Inc. (NASDAQ:POZN), today announced that Dr. Jay Goldstein, Professor of Medicine with the Department of Medicine, University of Illinois at Chicago and lead presenter for a PN 200 concept trial (immediate release omeprazole 20 mg, and enteric coated naproxen 500 mg), gave a podium presentation on the PN 200 study results at Digestive Disease Week on May 18, 2008.
